Since it is also known that patients with MDD suffer cognitive impairment [19]–[21] even in remission [22], we examined the correlation between serum levels of proBDNF, mature BDNF, and MMP-9, with clinical variables, including depression and cognition, in patients with MDD. Here, MMP9 is linked to depressive symptom measurement.